ITSN1 and inflammatory bowel disease: In the clinical field, lnc-ITSN1-2 expression correlates with RA risk and IBD risk, and it correlates with elevated disease activity in patients with RA and patients with IBD (Gong et al. 2017; Nie and Zhao 2020; Yue et al. 2019).